ArdorComm Media Group

Contact Us
logo
Menu
logo
ArdorComm ArdorComm ArdorComm

Healthcare Technology

NeueHealth to Be Acquired by NEA Affiliate in $1.3 Billion Deal

Leave a Comment / By / Human Resource Community

NeueHealth, a leading company in value-based care solutions that connects providers and payers through technology, has entered a definitive merger agreement to be acquired by an affiliate of New Enterprise Associates (NEA). The deal, valued at $1.3 billion, will transition NeueHealth into a privately held company. As part of the agreement, common stockholders of NeueHealth will receive $7.33 per share in cash—a 70% premium over the closing price of the company’s stock as of December 23. Additionally, 12 existing NeueHealth investors, along with NEA, have agreed to rollover agreements, exchanging their existing shares for equity in the newly privatized entity. The company’s current secured loan facility with Hercules Capital will remain intact, ensuring continuity in financial operations. NeueHealth’s executive leadership team will retain their roles post-merger, with the leadership rolling over their equity interests into the private company. Subject to stockholder and regulatory approvals, the merger is anticipated to enhance NeueHealth’s market position while delivering strong returns to its public stockholders. Mike Mikan, President and CEO of NeueHealth, commented on the development: “We are pleased to announce this transaction as we believe it places NeueHealth in a strong position for continued growth while maximizing value for all of NeueHealth’s public stockholders. NEA has been a longstanding strategic partner, and we look forward to continuing to work together to build on NeueHealth’s success as a leader in value-based care.” THE LARGER TREND NeueHealth has made significant strides in recent years. In 2024, it acquired the remaining 25% equity interest in Centrum Health, solidifying its ownership of the value-driven clinic brand. The company also secured a $150 million loan facility from Hercules Capital to bolster its operational priorities. Last year, Bright Health Group adopted NeueHealth as its corporate brand name, emphasizing its focus on value-based care solutions. NeueHealth’s common stock began trading under the ticker symbol NEUE on the NYSE, showcasing its growing prominence in the healthcare sector. This merger with NEA is expected to propel NeueHealth toward further growth and innovation, reinforcing its leadership in value-based care. Source: mobihealthnews Photo Credit: mobihealthnews

AI Early Detection System Prevents Strokes by Identifying Atrial Fibrillation

Leave a Comment / By / Health & Wellness Community
News on Health

Researchers have harnessed the power of artificial intelligence (AI) to identify irregular cardiac rhythms in individuals who have not yet exhibited symptoms. This AI system, which detected hidden signals in routine medical diagnostic tests, offers a promising avenue for doctors to proactively prevent strokes and other cardiovascular problems in individuals with atrial fibrillation, the most common type of heart rhythm disorder. While previous algorithms were predominantly tested on a narrow demographic, this new AI algorithm demonstrates effectiveness across various situations and patient populations, including veterans and underserved communities in the United States. The groundbreaking findings have been published in JAMA Cardiology, a reputable peer-reviewed journal. Dr. David Ouyang, a cardiologist at Cedars-Sinai’s Smidt Heart Institute and a researcher in the Division of Artificial Intelligence in Medicine, is the senior author of this study. He emphasizes the significance of this research in identifying concealed heart conditions and promoting the development of equitable and universally applicable algorithms for all patients. According to experts, approximately one in three people with atrial fibrillation remains undiagnosed. In this condition, the heart’s electrical signals, responsible for orchestrating the flow of blood from the upper chambers to the lower chambers, become chaotic. This can result in blood pooling in the upper chambers, leading to the formation of blood clots that may travel to the brain and trigger an ischemic stroke. The core of this groundbreaking discovery lies in an AI algorithm that was trained to recognize patterns within electrocardiogram (ECG) readings. ECG is a diagnostic test that monitors the heart’s electrical activity, typically involving the placement of electrodes on a patient’s body to capture these signals. By analyzing nearly one million ECGs, the AI model was not only able to accurately predict the onset of atrial fibrillation within 31 days but also demonstrated its effectiveness when applied to medical records of patients at Cedars-Sinai. Dr. Sumeet Chugh, the director of the Division of Artificial Intelligence in Medicine and the medical director of the Heart Rhythm Center at the Department of Cardiology, highlights the study’s geographic and ethnic diversity in its sample of veterans. This diversity underscores the potential of this algorithm to benefit a broad spectrum of the U.S. population. The research is a testament to the innovative ways in which AI is being harnessed at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine to proactively manage complex and challenging cardiac conditions.